Omega-3 polyunsaturated fatty acids (PUFAs) exhibit neuroprotective properties and
represent a potential treatment for a variety of neurodegenerative and neurological disorders. …

Polyunsaturated fatty acids (PUFAs) are structural components of membrane phospholipids,
and influence cellular function via effects on membrane properties, and also by acting as a …

Spinal cord injury (SCI) is a cause of major neurological disability, and no satisfactory treatment
is currently available. Evidence suggests that polyunsaturated fatty acids (PUFAs) could …

Retinoic acid receptors (RARs), retinoid X receptors (RXRs), and peroxisome proliferator‐activated
receptors (PPARs) are transcription factors involved in many cellular processes, such …

Polyunsaturated fatty acids (PUFA) of the omega-3 series and omega-6 series modulate
neurite outgrowth in immature neurones. However, it has not been determined if their …

The brain is enriched in arachidonic acid (ARA) and docosahexaenoic acid (DHA), long-chain
polyunsaturated fatty acids (LCPUFAs) of the n-6 and n-3 series, respectively. Both are …

Background. Mobility is a key determinant of frailty in older persons, and a variety of dietary
factors, such as the omega-3 fatty acid docosahexaenoic acid (DHA), are positively …

Functional recovery after a peripheral nerve injury (PNI) is often poor. There is a need for
therapies that protect neurons against injury and enhance regeneration. Omega-3 …

Amyotrophic lateral sclerosis (ALS) is a progressive fatal neurodegenerative disease
characterised by loss of motor neurons that currently has no cure. Omega-3 polyunsaturated fatty …

Rationale: Traumatic brain injury (TBI) leads to neurological impairment, with no satisfactory
treatments available. Classical ketogenic diets (KD), which reduce reliance on …